Open AccessP101: Combination of immune checkpoint inhibitors with BeGEV in the treatment of patients with relapsed and refractory classical Hodgkin's lymphoma.
HemaspherePeer ReviewedMangasarova Ya.K. +132022Journals
The content you want is available to Zendy users.
Already have an account? Sign inHaving issues? Contact support